Brief: Frequency Therapeutics Provides Business Updates, Reports Fourth Quarter
15/03/2022 11:40
March 15 (Reuters) - Frequency Therapeutics Inc FREQ.O :
* FREQUENCY THERAPEUTICS PROVIDES BUSINESS UPDATES AND
REPORTS
FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
* QTRLY NET LOSS PER SHARE $0.62
* Q4 EARNINGS PER SHARE VIEW $0.15 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw8YcSYla
Further company coverage: FREQ.O
Recent news on Korro Bio
See all newsBrief: Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Korro Announces First Cohort Dosed In Phase 1/2 Clinical Trial (Anchor) For Krro-121
Brief: Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Korro Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Korro Bio, Inc. expected to post a loss of $1.43 a share - Earnings Preview